CABALETTA BIO, INC. (CABA) Operating cash flow 2018–2025
CABALETTA BIO, INC. (CABA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$131.1MFY2025 · since FY2018: -$4.7M → -$131.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$131.1M | -48.6% |
| FY2024 | -$88.2M | -64.8% |
| FY2023 | -$53.5M | -15.5% |
| FY2022 | -$46.4M | -36.0% |
| FY2021 | -$34.1M | -27.4% |
| FY2020 | -$26.8M | -66.8% |
| FY2019 | -$16.0M | -244.2% |
| FY2018 | -$4.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CABA financial trends
CABA RevenueCABA Net incomeCABA Net marginCABA Gross profitCABA Gross marginCABA Operating incomeCABA Operating marginCABA Free cash flowCABA Capital expendituresCABA Return on equityCABA Stock buybacksCABA Dividends paidCABA Total assetsCABA Total liabilitiesCABA Shareholders’ equityCABA overview →